Type I Interferon Shapes Humoral Immunity to SARS-CoV-2
Goldman-Israelow B, Mao T, Song E, Lu P, Wong P, Lucas C, Klein J, Iwasaki A. Type I Interferon Shapes Humoral Immunity to SARS-CoV-2. The Journal Of Immunology 2021, 206: 114.07-114.07. DOI: 10.4049/jimmunol.206.supp.114.07.Peer-Reviewed Original ResearchSARS-CoV-2 infectionIFN-I levelsFollicular helper T cellsSARS-CoV-2Helper T cellsRole of IFNType I interferonT cellsI interferonSARS-CoV-2 antibodiesSARS-CoV-2 IgGSARS-CoV-2 S1Anti-S1 IgAIFNAR-deficient miceCOVID-19 pathogenesisCOVID-19 patientsHumoral immune responsePotent antibody responsesAntibody-secreting cellsCOVID-19 morbidityGerminal center B cellsPlasma IFNIgG levelsLymph nodesHumoral immunityDiverse Functional Autoantibodies that Underlie Immune Perturbations in COVID-19
Mao T, Wang E, Klein J, Dai Y, Huck J, Liu F, Zheng N, Zhou T, Goldman-Israelow B, Wong P, Lucas C, Silva J, Oh J, Song E, Perotti E, Fischer S, Campbell M, Fournier J, Wyllie A, Vogels C, Ott I, Kalinich C, Petrone M, Watkins A, Cruz C, Farhadian S, Schulz W, Grubaugh N, Ko A, Iwasaki A, Ring A. Diverse Functional Autoantibodies that Underlie Immune Perturbations in COVID-19. The Journal Of Immunology 2021, 206: 114.04-114.04. DOI: 10.4049/jimmunol.206.supp.114.04.Peer-Reviewed Original ResearchSARS-CoV-2 infectionClinical outcomesSARS-CoV-2 resultsPre-existing autoantibodiesPrevalence of autoantibodiesAntiviral antibody responseCOVID-19 pathogenesisCOVID-19 patientsCOVID-19SARS-CoV-2COVID-19 diseaseFunctional autoantibodiesMurine surrogateAutoantibody responseImmune activationImmune perturbationsAutoantibody repertoireAntibody responseAutoantibody targetsSevere diseaseImmunological functionsAutoantibodiesMouse modelUninfected controlsAbstract Infection